BeOne Medicines
ONC
#605
Rank
A$60.52 B
Marketcap
A$535.03
Share price
1.90%
Change (1 day)
6.27%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): A$8.75

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$8.60. In 2025 the company made an earnings per share (EPS) of A$3.92 an increase over its 2024 EPS that were of A-$8.97.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$8.75123.1%
2025A$3.92-143.75%
2024A-$8.97
2022A-$28.0328.21%
2021A-$21.86-19.96%
2020A-$27.3220.81%
2019A-$22.6131.52%
2018A-$17.19417.57%
2017A-$3.32-37.16%
2016A-$5.29158.95%
2015A-$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.13-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.37-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA